In cerebral oedema there is an increase in brain water content. Therapy is aimed at either removing this fluid or decreasing its formation. I In post-traumatic cerebral oedema a number of therapeutic measures have been employed including osmotherapy. 2 
-4 Case 1
A 54-year-old man was admitted postoperatively to the Intensive Care Unit (lCU), having suffered a traumatic subdural and subarachnoid haemorrhage. The patient was intubated and ventilated prior to elevation of depressed skull fractures and insertion of a subdural catheter after surgery. Ventilation was continued to maintain a PaC02 of 30-35 mmHg and a Pa02 greater than 80 mmHg. The blood pressure was 120/80 mmHg, central venous pressure 7.5 cm H 2 0, pulse rate lOO/minute and mean intracranial pressure 35-40 mmHg. Specific therapy for cerebral oedema, begun on admission, consisted of glycerollO% 150 ml IV 6 hourly, mannitol 200/0, 100 ml IV 6 hourly, and dexamethasone, 8 mg IV 4 hourly. 5% dextrose and 1/5 normal saline in dextrose water were administered to maintain a 24-hour urine volume of approximately 2 litres or more. A progressive rise in serum creatinine occurred which reflected an acute non-oliguric renal failure of uncertain aetiology. 5 Biochemical measurements, details of osmotic therapy, fluid and sodium balance are shown in Tables 1 and 2 . The acute fall of plasma sodium to 115 mmolll on day 4 was interpreted as reflecting a hypo-osmolal state and correction was attempted with 250 mmol intravenous sodium chloride (5 mmollml) over one hour, followed by 350 mmol over the next 48 hours. Although the patient was discharged from ICU breathing spontaneously via a tracheostomy, he died in hospital eleven days after the injury.
Case 2
A 15-year-old, previously fit, 60 kg male, with multiple closed skull fractures and cerebral oedema, identified on computerised axial tomography, was admitted to ICU. Systolic blood pressure was 140 mmHg, pulse rate 110Iminute and on controlled ventilation arterial gas analysis showed pH 7.45, P a02 100 mmHg, and PaC02 33 mmHg. The chest x-ray was normal. The patient was ventilated to maintain a PaC02 of 33-35 mmHg and intravenous therapy consisted of 5% dextrose in water, 1500 mllday for 3 days, supplemented on the third day with a pre-mixed solution of Synthamin '17'(R) and 70% dextrose 500 mllday, which was continued for 3 days.
Therapy for cerebral oedema was begun on admission and continued for 7 days. This consisted of dexamethasone, mannitol 20%, and lasix 20 mg IV 12 hourly (see Table 3 ).
For the first 6 days, a negative fluid balance of 6 litres was recorded, but it may have been greater due to a persistent pyrexia of 39-40 QC. The progression of biochemical parameters is shown in Table 4 . On day 7 an acute severe hyperosmolal state was demonstrated and intravenous rehydration with 0.45% saline was begun, effectively correcting the recorded negative fluid balance over 24-36 hours. The patient was discharged comatose with a tracheostomy to a ward 11 days later with normal biochemistry.
DISCUSSION
The first case illustrates problems arising in the interpretation and treatment of hypoosmolality and hyponatraemia.
The calculation of osmolarity is achieved using a relatively standard formula, although variations have been proposed. 6 • 7 In this study, osmolarity was calculated from the solution constituent concentrations of plasma thus The measurement of serum osmolality via cryoscopy yields values which under normal metabolic conditions correlate well with calculated osmolarity. The difference between serum osmolality and calculated osmolarity is the osmolal gap6.8 (mean value 6.5 in this institution). The osmolal gap is elevated in a number of pathological states - DAY recovered in the urine of normal subjects in 9-11 hours. Both substances contribute an osmotic load to the extracellular fluid, mannitol, 1 mosmollkg/7.6 g dose and glycerol approximately twice as much. " · '2 In the first case, the plasma sodium of 115 mmolll and calculated osmolarity of 265 mosmolll were assumed to reflect a hypoosmolal state.
Hypo-osmolality has as its sole cause hyponatraemia, either absolute or dilutional. '3 Mannitol acutely induces a dilutional hyponatraemia which follows a water shift from the intra-to extracellular compartment, with no nett movement of sodium. Obligatory urinary sodium loss occurs in normal subjects after the plasma sodium concentration has returned to normal. l4 , 15 The hyponatraemia under discussion probably had a multifactorial origin: natriuresis as a consequence of prolonged use of osmotic diuretics, low sodium input and the dilutional effect of mannitol. '6 The presence of mannitol in the patient's plasma was refelcted in the elevated osmolal gap (40 on day 4).
The administration of sodium chloride to correct any absolute sodium deficit that may have existed was justified. However, the hypernatraemia on day 7 indicates that overcorrection occurred. This probably resulted from failure to recognise the contributon of the dilutional effect of mannitol in producing the observed hyponatraemia.
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During prolonged mannitol therapy the measurement of serum osmolality and calculation of the osmolal gap should alert the physician to the presence of dilutional hyponatraemia and decrease the likelihood of injudicious therapy with excessive sodium chloride.
Case 2 illustrates a second complication of osmotherapy, the induction of an acute hyperosmolal state.
The acute mobilisation of brain water requires a blood/brain osmolal gradient of 10-30 mosmoles.,,'8 This must be balanced against the necessity to ensure that serum osmolality does not exceed 330-350 mosmollkg H20. '8-20 In the second patient the osmolal gap of approximately 22, present at 0700 hours on day 7 ( Table 3 ), implies that the serum osmolality exceeded 350 mosmol during the rest of that day. Disturbances of the conscious state are known to occur at levels of 350 mosmollkg H 2 0, or during rapid increases of osmolality of at least 50 mosmol. Mortality rates of 80070 19, 21, 22 In this case the components of hyperosmolality were acute hyperglycaemia and uraemia, and a continued presence of mannitol, as indicated by a raised osmolal gap (Table 3) . Hyperosmolality here coexisted with hypertonicity, a condition which implies increased concentrations of impermeant extracell ular fluid solutes (glucose and mannitol) and net intracellular volume depletion. 21 The factors responsible include pyrexia and dehydration with renal dysfunction, diuretic and corticosteroid therapy and the administration of hyperosmolal intravenous fluids. Dehydration probably played a role by reducing the glomerular filtration rate and also as a distinct aetiological factor in the generation of hyperglycaemic hyperosmolality. [24] [25] [26] [27] Increased plasma concentrations of urea and glucose, after an initial period of disequilibrium are accompanied by the generation of intracellular 'idiogenic' osmoles which maintain brain cellular volume.
22 , 23 However, acute profound rises, as occurred in this patient may overwhelm this regulatory mechanism and lead to brain cell dysfunction.
22 , 23 In a critically ill patient, such an added osmolal burden is undesirable. In addition prolonged aggressive osmotherapy may cause brain intracellular osmolality to be "reset" to a higher level, thus effectively antagonising the action of osmotic agents.
28 The continued use of high dose corticosteroids, which would exacerbate hyperglycaemia and uraemia appears unwarranted. 29 -31 In the light of the complications of osmotherapy illustrated in these two cases it is recommended 1. that serum osmolality should be routinely measured during osmotherapy and any hyponatraemia interpreted in the context of a calculated osmolal gap, and 2. that aggressive osmotherapy and high dose corticosteroid therapy leading to the generation and exacerbation of a hyperosmolar state should not be undertaken.
